CA1338445C - 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents - Google Patents
1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agentsInfo
- Publication number
- CA1338445C CA1338445C CA000540932A CA540932A CA1338445C CA 1338445 C CA1338445 C CA 1338445C CA 000540932 A CA000540932 A CA 000540932A CA 540932 A CA540932 A CA 540932A CA 1338445 C CA1338445 C CA 1338445C
- Authority
- CA
- Canada
- Prior art keywords
- amino
- hydrocarbyl
- hydroxy
- independently
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
- C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91190686A | 1986-09-25 | 1986-09-25 | |
| US911,906 | 1986-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1338445C true CA1338445C (en) | 1996-07-09 |
Family
ID=25431084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000540932A Expired - Fee Related CA1338445C (en) | 1986-09-25 | 1987-06-30 | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2668232B2 (enExample) |
| CA (1) | CA1338445C (enExample) |
| DE (2) | DE3790581B4 (enExample) |
| GB (1) | GB2203151B (enExample) |
| WO (1) | WO1988002366A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5175287A (en) * | 1986-09-25 | 1992-12-29 | S R I International | Process for preparing 1,2,4-benzotriazine oxides |
| US5616584A (en) | 1986-09-25 | 1997-04-01 | Sri International | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| IE62911B1 (en) * | 1988-03-18 | 1995-03-08 | Stanford Res Inst Int | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| GR1000941B (el) * | 1989-03-17 | 1993-03-16 | Stanford Res Inst Int | Μεθοδος παρασκευης οξειδιων 1,2,4,βενζοτριαζινης. |
| EP0478545B1 (en) * | 1989-09-18 | 1999-08-11 | Sri International | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| US5672702A (en) * | 1995-12-04 | 1997-09-30 | Sanofi | Process for preparing 3 amino 1, 2, 4-benzotriazine dioxide |
| JP2015500295A (ja) * | 2011-12-07 | 2015-01-05 | エスアールアイ インターナショナルSRI International | ヒト結核菌を標的とする医薬としてのベンゾトリアジンオキサイド類 |
| US10981953B2 (en) | 2013-12-26 | 2021-04-20 | Toagosei Co, Ltd. | Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin |
| JP6872713B2 (ja) | 2015-05-29 | 2021-05-19 | 東亞合成株式会社 | 腫瘍細胞の放射線感受性を増大させる合成ペプチド及びその利用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2489352A (en) * | 1946-04-10 | 1949-11-29 | Merck & Co Inc | Halogen compounds of 3 aminobenzotriazine 1, 2, 4 oxide-1 |
| US2489359A (en) * | 1947-01-10 | 1949-11-29 | Merck & Co Inc | Benzotriazines |
| CH487171A (de) * | 1963-10-22 | 1970-03-15 | Siegfried Ag | Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine |
| DE1809390A1 (de) * | 1968-11-16 | 1970-06-11 | Bayer Ag | Phosphor-,Phosphon- bzw.Thionophosphor-(-phosphon)-saeureester und Verfahren zu ihrer Herstellung |
| IE38778B1 (en) * | 1973-02-02 | 1978-05-24 | Ciba Geigy | New 1,2,4-benzotriazine derivatives |
| DE2538179C2 (de) * | 1975-08-27 | 1986-05-28 | Bayer Ag, 5090 Leverkusen | 3-Alkoxy-benzo-1,2,4-triazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide |
| DE2740887A1 (de) * | 1977-09-10 | 1979-03-22 | Bayer Ag | Mittel zur bekaempfung von pflanzenbakteriosen |
-
1987
- 1987-06-16 GB GB8810634A patent/GB2203151B/en not_active Expired - Lifetime
- 1987-06-16 DE DE3790581A patent/DE3790581B4/de not_active Expired - Lifetime
- 1987-06-16 DE DE19873790581 patent/DE3790581T1/de active Pending
- 1987-06-16 JP JP62504083A patent/JP2668232B2/ja not_active Expired - Lifetime
- 1987-06-16 WO PCT/US1987/001412 patent/WO1988002366A1/en not_active Ceased
- 1987-06-30 CA CA000540932A patent/CA1338445C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2668232B2 (ja) | 1997-10-27 |
| JPH01500826A (ja) | 1989-03-23 |
| WO1988002366A1 (en) | 1988-04-07 |
| GB8810634D0 (en) | 1988-07-06 |
| DE3790581T1 (enExample) | 1988-08-25 |
| GB2203151B (en) | 1991-05-29 |
| DE3790581B4 (de) | 2004-12-23 |
| GB2203151A (en) | 1988-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6828321B2 (en) | 1,2,4-Benzotriazine oxides as radiosensitizers and selective cytotoxic agents | |
| US5175287A (en) | Process for preparing 1,2,4-benzotriazine oxides | |
| US6277835B1 (en) | Method of tumor treatment | |
| US5041653A (en) | Substituted benzamide radiosensitizers | |
| US5032617A (en) | Substituted benzamide radiosensitizers | |
| CA1338445C (en) | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents | |
| AU646794B2 (en) | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents | |
| CA1339217C (en) | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents | |
| CA2001903C (en) | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents | |
| KR19990079186A (ko) | 방사선 감응제 및 선택적인 세포독성제로서의 1,2,4-벤조트리아진 산화물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |